The
global Companion Animal Diagnostic Services Market is
expected to reach USD 12.25 billion by 2030, registering a CAGR of 7.35% over
the forecast period, according to a new report by Grand View Research, Inc. The
market is driven by increasing advancements in pet diagnostics, expansion of
service offerings by key market players, pet insurance penetration,
rising pet expenditure, and growing pet health concerns. The North American Pet
Health Insurance Association (NAPHIA) for instance, reported that about 3.88
million dogs in the U.S. are insured, while about 0.96 million cats have
insurance policies. This represented about 22% growth in total insured pets
over 2022. As more pet owners opt for insurance coverage, the demand for
veterinary services, including diagnostic services is anticipated to increase
in the coming years.
The
COVID-19 pandemic had both positive and negative impacts on the market. This
included limited access to veterinary care, operational challenges,
awareness about pet health, concerns over zoonoses, and supply chain
bottlenecks. In 2022, however, the market experienced a dampened growth rate
owing to the macroeconomic challenges brought on by high input costs and other
factors. For example, Neogen Corporation reported a decrease in domestic pet
genomics services revenue owing to a difficult comparison from strong 2021
sales growth. While IDEXX reported a notable impact on its gross profit in 2022
owing to higher service costs (including facility, labor, and product costs)
and high freight and distribution costs. However, as diagnostic and healthcare
standards that people expect for themselves continue to extend to their pets,
it is estimated to drive the demand for sophisticated diagnostic services over
the forecast period.
Increasing
adoption of pet insurance is a key market driver. Diagnostic services can
sometimes be expensive, particularly for advanced procedures like MRI scans
or genetic testing. Pet insurance mitigates the financial burden on pet owners,
making it more feasible for them to opt for these services when recommended by
veterinarians. Also, pet insurance policies often cover a portion of or the
entire cost of diagnostic services, including laboratory tests, imaging, and
other medical procedures. Pet owners who have insurance are more likely to take
their pets to the veterinarian regularly, increasing the likelihood of early
disease detection through diagnostics. This proactive approach not only
improves the pet's health outcomes but also reduces the overall cost of
treatment by addressing issues in their early stages.
List of Key Players in the Companion Animal Diagnostic
Services Market
- Zoetis
Services LLC
- IDEXX
Laboratories, Inc.
- Mars Inc.
- The Animal
Medical Center
- Embark
Veterinary, Inc.
- SYNLAB
- NationWide
Laboratories
- IVC
Evidensia
- CVS Group
Plc
- Greencross
Vets
Related Press
Release@ Companion Animal Diagnostic Services Market Report
Companion Animal Diagnostic Services Market Report
Highlights
- The
diagnostic and healthcare standards that people expect for themselves are
extending to their pets, driving demand for sophisticated diagnostic
services
- By Testing
Category, the Clinical Chemistry segment dominated the market with a share
of over 20% in 2022. The Cytopathology segment on the other hand, is
estimated to witness the highest growth rate of more than 9% in the coming
years
- In terms of
Type, the Point-of-Care (POC) segment dominated the market in 2022. The
Laboratory-based segment is projected to grow at the fastest rate of over
7% during the forecast period
- Dogs
accounted for the highest share of about 55% of the market by animal type
in 2022. Other companion animals segment is estimated to witness the
highest CAGR of over 9% in the near future
- As pets live
longer, the prevalence of age-related conditions and chronic diseases
increases, leading to a higher demand for diagnostic services.
Furthermore, the rise in pet insurance adoption encourages pet owners to
seek comprehensive diagnostic testing for their pets, as insurance
coverage can offset costs
- In 2022,
North America held the highest share of over 35% of the market by region.
The Asia Pacific region is expected to grow at the fastest rate of over 9%
during the forecast period
- The COVID-19
pandemic and other zoonotic disease outbreaks have underscored the
importance of monitoring and diagnosing diseases that can be transmitted
between animals and humans thus fueling the market growth
Companion Animal Diagnostic
Services Market Report Scope
Report tribute |
Details |
The market size value in 2023 |
USD 7.45 billion |
The revenue forecast in 2030 |
USD 12.25 billion |
Growth rate |
CAGR of 7.35% from 2023 to 2030 |
Base year for estimation |
2022 |
Historical data |
2018 - 2021 |
Forecast period |
2023 - 2030 |
Request For A Free Consultation @ https://www.grandviewresearch.com/request-free-consultation/455559/rfc
Companion Animal Diagnostic Services Market Segmentation
Grand
View Research has segmented the global companion animal diagnostic services
market based on testing category, type, animal type, and region:
Companion Animal Diagnostic Services Testing Category
Outlook (Revenue, USD Million, 2018 - 2030)
- Clinical
Chemistry
- Microbiology
- Parasitology
- Histopathology
- Cytopathology
- Hematology
- Immunology
& Serology
- Imaging
- Molecular
Diagnostics
- Other
Categories
Companion Animal Diagnostic Services Type Outlook
(Revenue, USD Million, 2018 - 2030)
- Point-of-Care
(POC)
- By Testing
Category
- Clinical
Chemistry
- Microbiology
- Parasitology
- Histopathology
- Cytopathology
- Hematology
- Immunology
& Serology
- Imaging
- Molecular
Diagnostics
- Other
Categories
- Laboratory-based
- By Testing
Category
- Clinical
Chemistry
- Microbiology
- Parasitology
- Histopathology
- Cytopathology
- Hematology
- Immunology
& Serology
- Imaging
- Molecular
Diagnostics
- Other
Categories
Companion Animal Diagnostic Services Animal Type Outlook
(Revenue, USD Million, 2018 - 2030)
- Dogs
- Cats
- Horses
- Other
Companion Animals
Companion Animal Diagnostic Services Regional Outlook
(Revenue, USD Million, 2018 - 2030)
- North
America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Netherlands
- Sweden
- Denmark
- Asia Pacific
- Japan
- China
- India
- South Korea
- Australia
- Latin
America
- Brazil
- Mexico
- Middle East
& Africa
- South
Africa
- Saudi
Arabia
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment